Abstract | OBJECTIVE: METHODS: The study population comprised 82 unselected patients of predominantly Scandinavian ancestry with SLE according to current classification criteria. Serum samples were collected at baseline and serially for up to 2 years. SAP component and SAP- DNA complexes were measured by ELISA. Associations between SAP- DNA and clinical manifestations or serological findings were analyzed. Ninety healthy, age-matched blood donors served as controls. RESULTS: SLE patients had normal serum concentrations of SAP, whereas SAP- DNA complexes were decreased. Two-thirds of the SLE patients tested persistently SAP- DNA complex-negative. There was no relationship between the occurrence of SAP- DNA complexes and clinical manifestations. SAP- DNA-negative patients tended to have lower leukocyte counts and complement C3 levels, and higher erythrocyte sedimentation rates and C3d levels versus SAP- DNA-positive patients. There was an inverse association between the occurrence of anti- double-stranded DNA ( anti-dsDNA) antibodies and SAP- DNA complexes. Co-occurrence of SAP- DNA complexes and anti-dsDNA antibodies was demonstrated in only one SLE patient, implying that 81/82 patients were discordant for the presence of anti-dsDNA antibodies and SAP- DNA complexes. CONCLUSION: The decreased level of SAP- DNA complexes in SLE patients and the inverse relationship between these complexes and anti-dsDNA antibody supports the concept that SAP component is implicated in the clearance of cell nuclear debris.
|
Authors | Anne Voss, Ellen Holm Nielsen, Sven Erik Svehag, Peter Junker |
Journal | The Journal of rheumatology
(J Rheumatol)
Vol. 35
Issue 4
Pg. 625-30
(Apr 2008)
ISSN: 0315-162X [Print] Canada |
PMID | 18278838
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antibodies, Antinuclear
- Serum Amyloid P-Component
- Complement C3d
- DNA
|
Topics |
- Adult
- Antibodies, Antinuclear
(immunology)
- Blood Sedimentation
- Complement C3d
(analysis)
- DNA
(blood, immunology)
- Enzyme-Linked Immunosorbent Assay
- Female
- Humans
- Lupus Erythematosus, Systemic
(blood, immunology, physiopathology)
- Male
- Middle Aged
- Serum Amyloid P-Component
(metabolism)
|